Advertisement
Screener

Twist Bioscience Corporation (TWST) Material Contracts

Twist Bioscience Corporation Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2025-11-17: Form 10-K; Exhibit 10.72; Description Second Amendment to Lease by and between Twist Bioscience Corporation and ARE-San Francisco No. 32, LLC, dated November 13, 2025.
  • 2025-08-04: Form 10-Q; Exhibit 10.3; Description MES Software License Agreement by and between Twist Bioscience Corporation and Atlas Data Storage, Inc., dated May 2, 2025.
  • 2025-08-04: Form 10-Q; Exhibit 10.2; Description License Agreement by and between Twist Bioscience Corporation and Atlas Data Storage, Inc., dated May 2, 2025..
  • 2025-08-04: Form 10-Q; Exhibit 10.1; Description Contribution Agreement by and between Twist Bioscience Corporation and Altas Data Storage, Inc., dated May 2, 2025..
FiledFormExhibitDescription
2025-11-1710-K10.72Second Amendment to Lease by and between Twist Bioscience Corporation and ARE-San Francisco No. 32, LLC, dated November 13, 2025
2025-08-0410-Q10.3MES Software License Agreement by and between Twist Bioscience Corporation and Atlas Data Storage, Inc., dated May 2, 2025
2025-08-0410-Q10.2License Agreement by and between Twist Bioscience Corporation and Atlas Data Storage, Inc., dated May 2, 2025.
2025-08-0410-Q10.1Contribution Agreement by and between Twist Bioscience Corporation and Altas Data Storage, Inc., dated May 2, 2025.
2025-02-118-K10.2Amended and Restated 2018 Equity Incentive Plan and forms of agreements thereunder
2024-11-1810-K10.19Employment Agreement dated April 24, 2023 between Twist Bioscience Corporation and Robert Werner
2024-11-1810-K10.18Amended and Restated Employment Agreement dated September 2, 2024 between Twist Bioscience Corporation and Dennis Cho
2024-11-1810-K10.17Amended and Restated Employment Agreement dated September 9, 2022 between Twist Bioscience Corporation and William Banyai
2024-11-1810-K10.16Amended and Restated Employment Agreement dated September 9, 2022 between Twist Bioscience Corporation and Paula Green
2024-11-1810-K10.15Amended and Restated Employment Agreement dated September 9, 2022 between Twist Bioscience Corporation and James Thorburn
2024-11-1810-K10.14Amended and Restated Employment Agreement dated September 9, 2022 between Twist Bioscience Corporation and Emily Leproust
2024-11-1810-K10.13Consulting Agreement dated October 8, 2024 by and between Twist Bioscience Corporation and James Thorburn
2024-05-0210-Q10.1Amendment to Employment Agreement dated March 20, 2024 between Twist Bioscience Corporation and James Thorburn.
2024-02-0210-Q10.1Employment Agreement dated December 18, 2023 between Twist Bioscience Corporation and Adam Laponis.
2023-02-0710-Q10.1Amended and Restated Employment Agreement dated October 26, 2022 between Twist Bioscience Corporation and Patrick Finn.
2021-04-168-K10.1First Amendment to Lease dated April 13, 2021, between Twist Bioscience Corporation and PWII Owner, LLC
2020-12-238-K10.1Lease Agreement, dated December 18, 2020, between Twist Bioscience Corporation and PWII Owner, LLC
2020-02-1010-Q10.1Settlement Agreement among Agilent Technologies, Inc., Twist Bioscience Corp., Emily Leproust, Siyuan Chen and Solange Glaize, dated February 6, 2020
2019-05-238-K10.1Senior Business Advisor Agreement dated November 1, 2017.
2019-05-0210-Q10.2First Amendment to Lease by and between Twist Bioscience Corporation and ARE-San Francisco No. 32, LLC, dated March 21, 2019.
2019-05-0210-Q10.1Sixth Amendment to Lease by and between Twist Bioscience Corporation and ARE-San Francisco No. 19, LLC, dated February 8, 2019.
2019-02-078-K10.1Employment Agreement by and between Twist Bioscience Corporation and Martin Kunz.

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78